Cencora Inc. Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: November 4, 2026 results vs estimates
Cencora Inc. Forecast
Cencora Inc. short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 18.2% a year, a typical one-standard-deviation range is 322.03–339.03 over a week, 313.12–347.94 over a month and 270.22–390.84 over a year. (Signals as of 1 Nov 2026.)
Cencora Inc. Price Chart
Cencora Inc. Factors
YoY −51.7%
YoY −16.7%
YoY −52.2%
YoY −41.2%
YoY −15.3%
YoY +282.9%
YoY +106.9%
YoY +24.8%
YoY −11.2%
YoY +7.1%
YoY −30.1%
YoY +3.6%
YoY +11.9%
YoY +20.4%
YoY −26.5%
YoY +33.3%
Cencora Inc. fundamentals: income statement, balance sheet & cash flow
Cencora Inc. reported revenue of $337.40bn and net income of $3.48bn in FY2026, the year ended 30 September 2026 — revenue up 5.0% and net income up 124.2% on the prior year. Free cash flow was $3.88bn. These figures are as reported in the filings, not restated: 33 fiscal years and 128 quarters of history, back to September 1994. 134 FINRA short-interest settlements are published alongside them, back to June 2019.
| USD billions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 30 Sep 2026 | 30 Sep 2025 | 30 Sep 2024 | 30 Sep 2023 | 30 Sep 2022 |
| Revenue | 337.40 | 321.33 | 293.96 | 262.17 | 238.59 |
| Cost of revenue | 323.53 | 311.19 | 285.26 | 254.42 | 230.99 |
| Gross profit | 13.87 | 10.14 | 8.70 | 7.76 | 7.60 |
| Selling, general & admin. | 8.08 | 6.49 | 5.66 | 5.31 | 4.85 |
| Operating income | 3.93 | 3.65 | 3.04 | 2.45 | 2.75 |
| EBITDA | 6.12 | 3.75 | 3.37 | 3.42 | 3.12 |
| Interest expense | 0.49 | 0.42 | 0.25 | 0.28 | 0.23 |
| Pre-tax income | 4.58 | 2.26 | 2.00 | 2.16 | 2.18 |
| Income tax | 1.08 | 0.69 | 0.48 | 0.43 | 0.52 |
| Net income | 3.48 | 1.55 | 1.51 | 1.75 | 1.70 |
Download Cencora Inc. fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.COR.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Cencora Inc.
Explore MacroFinance macro & markets research and analysis.
Cencora Inc. Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Cencora Inc.; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Cencora Inc.’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Cencora Inc. (United States)
Cencora Inc. is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Camino Minerals Corporation
Frequently asked questions
What is Cencora Inc.?
What is the latest Cencora Inc. price?
Is Cencora Inc. in an uptrend?
How volatile is Cencora Inc.?
What factors affect Cencora Inc.?
Which trading strategies trade Cencora Inc.?
How are Cencora Inc. returns analysed?
Where can I download free Cencora Inc. historical data?
Free Cencora Inc. historical data (last 10 years)
Browse or instantly download the last 10 years of Cencora Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.COR.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 339.09 |
| 2026-11-19 | 341.25 |
| 2026-11-18 | 348.31 |
| 2026-11-17 | 350.56 |
| 2026-11-16 | 356.94 |
| 2026-11-13 | 359.03 |
| 2026-11-12 | 348.72 |
| 2026-11-11 | 349.219 |
| 2026-11-10 | 348.051 |
| 2026-11-09 | 345.107 |
About this stock
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.